For example, Miglustat (marketed as Zavesca®) is a small molecule inhibitor of the enzyme glucosylceramide synthase and is used to treat patients with Niemann‐Pick disease type C and Gaucher disease.31, 32. This evidence concerns the gene UGCG and Gaucher disease.